![](/img/cover-not-exists.png)
P3.02b-066 Phase II Trial of the C-Met Inhibitor Tepotinib in Advanced Lung Adenocarcinoma with MET Exon 14 Skipping Mutations after Failure of Prior Therapy
Paik, Paul, Stammberger, Uz, Bruns, Rolf, Overton, LindsayVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1733
Date:
January, 2017
File:
PDF, 125 KB
english, 2017